Oracle is a software infrastructure company located in California, United States, which is part of the Technology sector, and is traded under the ticker ORCL on the NYSE exchange.
Oracle stock last closed at $125.61, up 0.27% from the previous day, and has increased 39.8% in one year. It has overperformed other stocks in the Software - Infrastructure industry by 0.16 percentage points. Oracle stock is currently +40.02% from its 52-week low of $89.71, and -5.4% from its 52-week high of $132.77.
At the moment, there are 2.75B shares of ORCL outstanding. The market capitalization of ORCL is $345.24B. In the past 24 hours, 6.49M ORCL shares were traded.
You need a brokerage account in order to access the NYSE market and buy ORCL stock.
Based on our analysis, eToro is the best brokerage. eToro gives you:
Get $10 towards your stock purchase by signing up for an account with eToro today.
Open eToro AccountNow that you've selected your brokerage, the next step is to fill out some personal info so you are able to invest in ORCL stock today.
Now that you have created your account on app for investing, you need to deposit funds:
Watch the walkthrough below if you need help transferring money into your investment account.
After you have figured out the best place to buy Oracle stock, it's absolutely critical to research their stock before you invest, so you actually wrap your head around the risk and upside.
WallStreetZen was built to help everyday investors perform better fundamental analysis.
You can see all of the due diligence checks on ORCL's stock page.
You can use many financial metrics, analyses, models, and charts to gauge ORCL's true value.
Using relative valuations measures:
You can do more valuation research on ORCL's stock here.
Out of 19 Wall Street analysts who give ratings on ORCL, the consensus analyst rating on ORCL is a Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they investment advice.
Keith Bachman, a top 3% analyst from BMO Capital maintains ORCL with a hold rating and raises their ORCL price target from $126.00 to $142.00, on Mar 12, 2024.
Brad Reback, a top 9% analyst from Stifel Nicolaus maintains ORCL with a hold rating and raises their ORCL price target from $100.00 to $120.00, on Mar 12, 2024.
Stifel Nicolaus's Brad Reback raised their price target on Oracle (NYSE: ORCL) by 20% from $100 to $120 on 2024/03/12. The analyst maintained their Hold rating on the stock.
Although Oracle's cloud business was strong, its services division was sluggish, leading to results that were only in line with Street projections, Reback said to sum up the company's Q3 2024 print, reported on 2024/03/11.
Even though there will be some tailwinds from existing customer cloud migrations, new AI workloads, and Azure databases, the analyst still thinks Oracle's win rates won't change much because "other hyperscalers are spending more to build capacity earlier and keep their technological advantages."
For Q3 2024, Oracle reported:
For Q4 2024, management guided:
CEO Safra Catz commented: "Large new cloud infrastructure contracts signed in Q3 drove Oracle's total Remaining Performance Obligations up 29% to over $80B, an all-time record.
"We expect to continue receiving large contracts reserving cloud infrastructure capacity because the demand for our Gen2 AI infrastructure substantially exceeds supply—despite the fact we are opening new and expanding existing cloud data centers very, very rapidly.
"We expect that 43% of our current $80B of Remaining Performance Obligations will be recognized as revenue over the next four quarters and that our Gen2 Cloud Infrastructure business will remain in a hypergrowth phase—up 53% in Q3—for the foreseeable future."
Chairman and CTO Larry Ellison added: "In Q3, Oracle finished moving the majority of Cerner customers to Oracle's Gen2 Cloud Infrastructure.
"In Q4, Oracle will start delivering its completely new Ambulatory Clinic Cloud Application Suite to these same customers. This new AI-driven system features an integrated voice interface called the Clinical Digital Assistant that automatically generates doctors' notes and updates Electronic Health Records—saving precious time and improving health data accuracy.
"The delivery of this revolutionary new healthcare technology will enable the rapid modernization of our customers' health systems over the coming year, and transform Cerner and Oracle Health into a high-growth business for years to come."
Gil Luria, a top 14% analyst from DA Davidson maintains ORCL with a hold rating and announces their ORCL price target of $105.00, on Mar 12, 2024.
Karl Keirstead, a top 11% analyst from UBS maintains ORCL with a strong buy rating and raises their ORCL price target from $130.00 to $150.00, on Mar 12, 2024.
Keith Weiss, a top 2% analyst from Morgan Stanley maintains ORCL with a hold rating and raises their ORCL price target from $106.00 to $115.00, on Mar 12, 2024.
You can dig deeper into what analysts are forecasting on the Oracle stock forecast page.
Last year, ORCL earnings were $10.64B. During the last 5 year, ORCL's earnings have grown by 6.87% per year. This was slower than the Software - Infrastructure industry average of 132.67%.
Last year, ORCL revenue was $52.51B. In the past 5 year, ORCL's revenue has increased by 5.92% per year. This was slower than the Software - Infrastructure industry average of 17.22%.
You can research ORCL's earnings and revenue performance here.
In the last 12 months, insiders at ORCL have sold more shares than they have bought.
Safra Catz, Chief Executive Officer of ORCL, was the latest ORCL insider to sell. They sold $1,346,124.54 worth of ORCL shares on Mar 27, 2024.
Learn more about who owns ORCL stock here.
Oracle pays a dividend of 1.27%, compared to the Software - Infrastructure industry's average dividend yield of 40.83%. If you owned $1,000 of ORCL stock, you would have received $12.74 last year.
Oracle dividend payments have consistently grown over the past decade and have remained stable.
Find more info about Oracle dividend yield and history here.
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
There are two main options:
Press the Open Trade button and your broker will execute your order.
If you want additional assistance buying stocks on eToro, watch the helpful video below:
Now that you own some shares in ORCL, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to see the latest developments about your ORCL stock.
To reiterate, here are the 6 steps for buying Oracle stock:
If you require a brokerage account, eToro is our recommended option.
Get Started with eToro TodayIf you would like to keep track of your investment in Oracle, create a watchlist on WallStreetZen today.